BNP Paribas Financial Markets
DTIL icon

BNP Paribas Financial Markets’s Precision BioSciences DTIL Stock Holding History

BNP Paribas Financial Markets’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Buy
25,749
+25,667
+31,301% +$118K ﹤0.01% 4207
2025
Q4 		$341 Hold
82
– – ﹤0.01% 5513
2025
Q3 		$453 Hold
82
– – ﹤0.01% 5320
2025
Q2 		$344 Buy
82
+27
+49% +$133 ﹤0.01% 5251
2025
Q1 		$262 Sell
55
-97
-64% -$494 ﹤0.01% 5193
2024
Q4 		$579 Hold
152
– – ﹤0.01% 5153
2024
Q3 		$1.36K Hold
152
– – ﹤0.01% 3917
2024
Q2 		$1.48K Hold
152
– – ﹤0.01% 3835
2024
Q1 		$2.06K Sell
152
-1,836
-92% -$22.5K ﹤0.01% 3812
2023
Q4 		$21.8K Hold
1,988
– – ﹤0.01% 3655
2023
Q3 		$20.4K Buy
1,988
+1,835
+1,199% +$28.2K ﹤0.01% 3561
2023
Q2 		$2.41K Hold
153
– – ﹤0.01% 3717
2023
Q1 		$3.45K Sell
153
-841
-85% -$27.7K ﹤0.01% 3606
2022
Q4 		$35.5K Sell
994
-151
-13% -$5.97K ﹤0.01% 3473
2022
Q3 		$44.7K Buy
1,145
+138
+14% +$6.56K ﹤0.01% 4003
2022
Q2 		$48.3K Buy
1,007
+654
+185% +$38.4K ﹤0.01% 3566
2022
Q1 		$32.6K Sell
353
-157
-31% -$21.3K ﹤0.01% 3647
2021
Q4 		$113K Sell
510
-241
-32% -$67.3K ﹤0.01% 3556
2021
Q3 		$260K Buy
751
+191
+34% +$64.7K ﹤0.01% 2956
2021
Q2 		$210K Sell
560
-1,063
-65% -$319K ﹤0.01% 2855
2021
Q1 		$504K Buy
1,623
+1,419
+696% +$497K ﹤0.01% 2561
2020
Q4 		$51K Sell
204
-197
-49% -$48.3K ﹤0.01% 3549
2020
Q3 		$74.1K Buy
401
+344
+604% +$68.4K ﹤0.01% 3270
2020
Q2 		$14.3K Sell
57
-313
-85% -$68.5K ﹤0.01% 3543
2020
Q1 		$66.9K Buy
370
+231
+166% +$60.5K ﹤0.01% 3414
2019
Q4 		$58K Buy
139
+124
+827% +$39K ﹤0.01% 3563
2019
Q3 		$3.75K Buy
15
+14
+1,400% +$4.56K ﹤0.01% 4305
2019
Q2 		$318 Buy
+1
New +$403 ﹤0.01% 4437

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BNP Paribas Financial Markets's DTIL Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Precision BioSciences (DTIL) stake by 31,301% in Q1 2026, buying an estimated $118K and bringing the position to 25,749 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #4207.

BNP Paribas Financial Markets first reported a position in DTIL in Q2 2019 and has held it in 28 quarters since. The position peaked at $504K in Q1 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • BNP Paribas Financial Markets held 25,749 shares of Precision BioSciences worth $142K as of Q1 2026.
  • BNP Paribas Financial Markets bought 25,667 Precision BioSciences shares in Q1 2026, an estimated $118K.
  • Precision BioSciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4207 holding.
  • BNP Paribas Financial Markets first reported a position in Precision BioSciences in Q2 2019 and has held it in 28 quarters since.
  • BNP Paribas Financial Markets's Precision BioSciences position peaked at $504K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.